Cargando…

Brain amyloid and the transition to dementia in Down syndrome

INTRODUCTION: Down syndrome (DS) is associated with elevated risk for Alzheimer's disease (AD) due to amyloid beta (Aβ) lifelong accumulation. We hypothesized that the spatial distribution of brain Aβ predicts future dementia conversion in individuals with DS. METHODS: We acquired (18)F‐florbet...

Descripción completa

Detalles Bibliográficos
Autores principales:	Keator, David B., Doran, Eric, Taylor, Lisa, Phelan, Michael J., Hom, Christy, Tseung, Katherine, van Erp, Theo G. M., Potkin, Steven G., Brickman, Adam M., Rosas, Diana H., Yassa, Michael A., Silverman, Wayne, Lott, Ira T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7656170/ https://www.ncbi.nlm.nih.gov/pubmed/33204814 http://dx.doi.org/10.1002/dad2.12126

Ejemplares similares

Down syndrome: Distribution of brain amyloid in mild cognitive impairment
por: Keator, David B., et al.
Publicado: (2020)

Joint‐label fusion brain atlases for dementia research in Down syndrome
por: Queder, Nazek, et al.
Publicado: (2022)

Pathways linking pulse pressure to dementia in adults with Down syndrome
por: Rizvi, Batool, et al.
Publicado: (2023)

Obstructive sleep apnea, cerebrovascular disease, and amyloid in older adults with Down syndrome across the Alzheimer’s continuum
por: Lao, Patrick, et al.
Publicado: (2022)

Cognitive Function during the Prodromal Stage of Alzheimer’s Disease in Down Syndrome: Comparing Models
por: Hom, Christy L., et al.
Publicado: (2021)

Cognitive and Behavioral Domains That Reliably Differentiate Normal Aging and Dementia in Down Syndrome
por: Harp, Jordan P., et al.
Publicado: (2021)

Correction: Hom et al. Cognitive Function during the Prodromal Stage of Alzheimer’s Disease in Down Syndrome: Comparing Models. Brain Sci. 2021, 11, 1220
por: Hom, Christy L., et al.
Publicado: (2022)

Altered connectivity of the default mode network in cognitively stable adults with Down syndrome: “Accelerated aging” or a prelude to Alzheimer's disease?
por: Rosas, H. Diana, et al.
Publicado: (2021)

Language skills as a predictor of cognitive decline in adults with Down syndrome
por: Pulsifer, Margaret B., et al.
Publicado: (2020)

Cerebrovascular pathology in Down syndrome and Alzheimer disease
por: Head, Elizabeth, et al.
Publicado: (2017)

Impact of the COVID-19 pandemic on daily life, mood, and behavior of adults with Down syndrome
por: Hartley, Sigan L., et al.
Publicado: (2022)

Aging and Down Syndrome
por: Head, Elizabeth, et al.
Publicado: (2012)

A modified Cued Recall Test for detecting prodromal AD in adults with Down syndrome
por: Krinsky‐McHale, Sharon J., et al.
Publicado: (2022)

Research attitudes in families of individuals with Down syndrome: importance for clinical trials
por: Lott, Ira T., et al.
Publicado: (2022)

Functional Magnetic Resonance Imaging of Motor Cortex Activation in Schizophrenia
por: Lee, Hyo Jong, et al.
Publicado: (2015)

Regional binding of tau and amyloid PET tracers in Down syndrome autopsy brain tissue
por: Lemoine, L., et al.
Publicado: (2020)

The Alzheimer's Biomarker Consortium‐Down Syndrome: Rationale and methodology
por: Handen, Benjamin L., et al.
Publicado: (2020)

Functional network structure supports resilience to memory deficits in cognitively normal older adults with amyloid-β pathology
por: Adams, Jenna N., et al.
Publicado: (2023)

Detection of Brain Tau Pathology in Down Syndrome Using Plasma Biomarkers
por: Janelidze, Shorena, et al.
Publicado: (2022)

Cerebrospinal fluid biomarkers of Alzheimer's disease in a cohort of adults with Down syndrome
por: Henson, Rachel L., et al.
Publicado: (2020)

Distribution of microglial phenotypes as a function of age and Alzheimer's disease neuropathology in the brains of people with Down syndrome
por: Martini, Alessandra C., et al.
Publicado: (2020)

Assessing general cognitive and adaptive abilities in adults with Down syndrome: a systematic review
por: Hamburg, Sarah, et al.
Publicado: (2019)

Metabolic correlates of prevalent mild cognitive impairment and Alzheimer's disease in adults with Down syndrome
por: Mapstone, Mark, et al.
Publicado: (2020)

Promising outcome measures of early Alzheimer's dementia in adults with Down syndrome
por: Krinsky‐McHale, Sharon J, et al.
Publicado: (2020)

Plasma amyloid and tau as dementia biomarkers in Down syndrome: Systematic review and meta‐analyses
por: Alhajraf, Falah, et al.
Publicado: (2019)

Proteomic profiles for Alzheimer's disease and mild cognitive impairment among adults with Down syndrome spanning serum and plasma: An Alzheimer's Biomarker Consortium–Down Syndrome (ABC–DS) study
por: Petersen, Melissa E., et al.
Publicado: (2020)

Amyloid Imaging in Aging and Dementia: Testing the Amyloid Hypothesis In Vivo
por: Rabinovici, G. D., et al.
Publicado: (2009)

Amyloid accumulation in Down syndrome measured with amyloid load
por: Zammit, Matthew D., et al.
Publicado: (2020)

Amyloid precursor protein drives down-regulation of mitochondrial oxidative phosphorylation independent of amyloid beta
por: Lopez Sanchez, M. Isabel G., et al.
Publicado: (2017)

Beta-amyloid imaging in dementia
por: Chun, Kyung Ah
Publicado: (2018)

Alzheimer's risk and quality of life: History of Down syndrome as a case in point
por: Silverman, Wayne, et al.
Publicado: (2021)

Amyloid-Related Imaging Abnormalities With Anti-amyloid Antibodies for the Treatment of Dementia Due to Alzheimer's Disease
por: Withington, Charles G., et al.
Publicado: (2022)

Ophthalmic Disorders in Adults with Down Syndrome
por: Krinsky-McHale, Sharon J., et al.
Publicado: (2012)

Chemical Methods to Knock Down the Amyloid Proteins
por: Gao, Na, et al.
Publicado: (2017)

Amyloid imaging for dementia in clinical practice
por: O’Brien, John T., et al.
Publicado: (2015)

Amyloid‐dependent and amyloid‐independent effects of Tau in individuals without dementia
por: Therriault, Joseph, et al.
Publicado: (2021)

Mitral and tricuspid stenosis caused by light chain cardiac amyloid deposition
por: Randhawa, Varinder K., et al.
Publicado: (2020)

β-Amyloid PET and neuropathology in dementia with Lewy bodies
por: Kantarci, Kejal, et al.
Publicado: (2020)

Direct bone marrow HSC transplantation enhances local engraftment at the expense of systemic engraftment in NSG mice
por: Futrega, Kathryn, et al.
Publicado: (2016)

A fibril-specific, conformation-dependent antibody recognizes a subset of Aβ plaques in Alzheimer disease, Down syndrome and Tg2576 transgenic mouse brain
por: Sarsoza, Floyd, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_sdmq5mlo3tp06s08gbh876kpmu